Clinical Trials Logo

Peripheral Artery Disease clinical trials

View clinical trials related to Peripheral Artery Disease.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT05961163 Terminated - Stroke Clinical Trials

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study

CLIMATE
Start date: July 24, 2023
Phase:
Study type: Observational

The CLIMATE Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific efforts, somatosensory amplification, self-efficacy, health literacy and commitment to the GP, degree of urbanisation of the patients' administration district and characteristics of the patients' neighborhood are associated with these effects.

NCT ID: NCT05063474 Terminated - Clinical trials for Peripheral Artery Disease

Microvascular Reactivity in Peripheral Artery Disease

Start date: November 9, 2021
Phase:
Study type: Observational

Peripheral Artery Disease (PAD) is a major risk factor for lower limb amputation. Microvascular reactivity assessed with near-infrared spectrometry has been studied in people with PAD but not in people with limb loss (PLL) who have PAD. The purpose of this research is to explore whether near-infrared spectrometry measures can contribute to identifying people at risk for amputation. Specific aims include: 1) Determine the test-retest reliability of near-infrared spectrometry measures in people with peripheral artery disease with or without major unilateral amputation. 2) Determine construct validity of near-infrared spectrometry measures compared to 6-Minute Walk Test, and time to claudication onset; and self-reported prosthetic mobility in people with transtibial amputation. This methodologic prospective study with repeated assessments and long term phone follow-up every year to identify any subjects that undergo revascularization or amputation will include 2 groups of subjects: a PAD group enrolled from an out-patient walking program, and a PLL+PAD group who receive no care but have their walking step counts monitored.

NCT ID: NCT05034848 Terminated - Clinical trials for Peripheral Artery Disease

Peripheral Artery Disease (PAD) : Its Effects on Bone

AMICOS
Start date: March 31, 2021
Phase: N/A
Study type: Interventional

Prevalence of PAD and osteoporosis (OP) both get higher with age. Clinical and epidemiologic evidence have showed an increased cardiovascular risk in OP and bone loss and fragility fractures in patient with cardiovascular disease. This study will examine the relationship between vascular disease in legs and sBMD and vBMD at trabecular and cortical sites and bone microarchitecture.

NCT ID: NCT04335695 Terminated - Clinical trials for Peripheral Artery Disease

Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life

Start date: December 13, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to identify the type of patients being referred for the Vascular Rehabilitation Program (VRP) and to study the success rates of the program according to improvements in walking distance and quality of life surveys. Subjects will be in the VRP for 6-12 weeks and then be followed for 12 months after they complete the program. This is a single-site study at Baylor Scott & White Heart Hospital-Plano.

NCT ID: NCT04123093 Terminated - Diabetic Foot Ulcer Clinical Trials

Safety and Efficacy of the Noxsano Wound Care Bandage

Start date: August 9, 2019
Phase: N/A
Study type: Interventional

This study is a prospective, interventional, non-randomized study designed to assess the safety and efficacy of the Noxsano Bandage (study device) in healthy subjects and wound care subjects with a diabetic lower extremity ulceration and/or arterial insufficiency lower extremity ulceration.

NCT ID: NCT04120610 Terminated - Clinical trials for Peripheral Artery Disease

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia

Start date: December 9, 2019
Phase:
Study type: Observational [Patient Registry]

Non-randomized, multi-center, longitudinal study of healthy subjects and subjects with PAD who are scheduled for ABI, TBI, and either Duplex Ultrasound or Angiographic assessments in a vascular clinic.

NCT ID: NCT04010045 Terminated - Clinical trials for Peripheral Artery Disease

REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study

RESULTS
Start date: May 2, 2019
Phase:
Study type: Observational

This is an observational study of the DABRA Laser System and other medical devices intended for endovascular treatment of peripheral artery disease.

NCT ID: NCT03676842 Terminated - Clinical trials for Peripheral Artery Disease

Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB

FORTEZ
Start date: October 11, 2018
Phase: N/A
Study type: Interventional

Prospective, single-center, single-arm, non-randomized study to assess the safety and efficacy of the FLEX Scoring Catheter in patients with atherosclerotic peripheral artery disease in the superficial femoral and popliteal arteries.

NCT ID: NCT02767895 Terminated - Clinical trials for Peripheral Artery Disease

Prehabilitation for PAD Revascularization Patients

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

Patients undergoing elective revascularization of their peripheral artery disease will be randomized to a prehabilitation program or usual care prior to their scheduled procedure.

NCT ID: NCT02678403 Terminated - Clinical trials for Peripheral Artery Disease

Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral Artery Disease TENS-PAD Study / TENS-AOMI

TENS-PAD
Start date: August 16, 2018
Phase: N/A
Study type: Interventional

Purpose: The investigators team recently carried out a proof of concept study testing the efficacy of one single 45-minute session of 10 Hz TENS prior to walking, versus placebo. In this randomized study, the investigators found that TENS significantly delayed pain onset and increased the pain-free walking distance in patients with class II PAD. From these encouraging results, the investigators now seek to assess the efficacy of an intervention that includes the daily use of TENS for 3 weeks (5 days a week) on walking distance in PAD (Leriche-Fontaine stage II). Methods/Design: prospective multicentre study / randomized controlled trial / double blinding.